1. FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases – The PARLIM trial (AIO KRK 0314). (September 2022) Authors: Modest, Dominik Paul; Karthaus, Meinolf; Kasper, Stefan; Moosmann, Nicolas; Keitel, Verena; Kiani, Alexander; Uhlig, Jens; Jacobasch, Lutz; Fischer v. Weikersthal, Ludwig; Fuchs, Martin; Kaiser, Florian; Lerchenmüller, Christian; Sent, Dagmar; Junghanß, Christian; Held, Swantje; Lorenzen, Sylvie;... Journal: European journal of cancer Issue: Volume 173(2022) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗